Blood Coagulation: Overview, Definition, Factors, Facts, Signs and Treatment

What Is Blood Coagulation?

Blood coagulation or clotting is a complicated process in which blood is changed from liquid to gel, forming a blood clot to prevent maximum blood loss due to damage to the vessel. This vital function comprises a sequence of events through which the activation of platelets and plasma proteins takes place to form a stable fibrin clot.

Latest: NEET 2024 Paper Analysis and Answer Key 

Don't Miss: Most scoring concepts for NEET | NEET papers with solutions

New: NEET Syllabus 2025 for Physics, Chemistry, Biology

NEET Important PYQ & Solutions: Physics | Chemistry | Biology

What is Coagulation?

Coagulation is a crucial phase in the healing process of a wound when it functions as it should. Coagulation aids in the formation of a clot, which is made of a material called fibrin, when a blood vessel breaks, as with a cut or other damage. Until the tissues can heal themselves, the clot closes the wound.

Blood Coagulation Process

Blood coagulation represents a well-orchestrated sequence involving rapid and effective clotting. All these stages include vascular spasm, platelet plug formation, the coagulation cascade, clot retraction and repair, and finally fibrinolysis.

Vascular Spasm

• Vascular spasm refers to the instant contraction of blood vessels upon injury.

• Mechanism of Action: Smooth muscles in the blood vessel wall contract, reducing blood flow.

• In Blood Coagulation: It provides a temporary seal minimising blood loss.

Formation Of Platelet Plug

• The adherence of platelets to the site of injury and their subsequent aggregation by each other onto fibrinogen, thereby forming a temporary "plug".

Platelet Plug Formation Stages:

• Adhesion: The platelets are associated with exposed collagen fibres of the injured vessel.

• Activation: Chemicals released by the platelets attract more platelets.

• Aggregation: Platelets clump together, forming the plug.

• Platelets thus play a twin role in forming the plug and in initiating the coagulation cascade.

Side Effects of Coagulation Factors

When injected, coagulation factors may have the following adverse effects:

• Dyspnea (shortness of breath)

• Fever

• Nausea

• Dizziness

• Headache

• Taste disturbance

• Itching

• Rash

• Swelling or redness at the injection site

• Stuffy nose.

How Do Coagulation Factors Work?

Drugs called coagulation factor concentrates are used to treat haemophilia and control bleeding. A severe impairment of blood clotting caused by haemophilia causes considerable blood loss in the event of even a minor wound. Usually, it results from a hereditary deficiency in a coagulation factor, most frequently factor VIII. Blood-clotting proteins called coagulation factors are produced naturally in the human body. The body's many coagulation components combine to generate clots. The clots stop the body from losing too much blood.

In order for the blood to adequately clot, the missing blood clotting factor must be replaced during haemophilia treatment. To stop serious blood loss, coagulation factor concentrates take the place of the blood clotting factor and help the blood clot.

Coagulation Cascade

Enzymatic cascade leads to the formation of fibrin strands that stabilise the platelet plug.

Coagulation Cascade Pathways:

• Intrinsic Pathway: This pathway is triggered by an injury in the vascular wall.

• Extrinsic Pathway: It gets activated on trauma, and blood is lost from the lumen of the vessel.

• Common Pathway: The intrinsic and extrinsic pathways merge to yield the production of fibrin.

• The involved factors range from I to XIII and include thrombin-like enzymes.

Clot Retraction and Repair

• Shrinking of the clot itself to reduce its size, drawing the edges of the wound closer together.

• Mechanism of Clot Retraction: Platelets contract, pulling on fibrin strands.

• Process for Tissue Repair and Generation: Tissue repair mechanisms are activated.

Fibrinolysis

• The breakdown of the clot after the vessel has healed itself.

• Plasminogen activates plasmin, which digests fibrin.

• Plasmin is the major proteolytic enzyme responsible for clot dissolution.

Clotting Time

Clotting timings gauge how long it takes for a clot to develop. In the majority of tests, an activator is utilised to start coagulation and assess how well one or more parts of the coagulation cascade model respond. A reduced number or function of the coagulation components involved might cause abnormalities in clotting times.

Prothrombin time (PT) and activated partial thromboplastin time are the two clotting times measurements that are most frequently utilised (aPTT).

Most clinical pathology laboratories offer these tests, which are often carried out by automated coagulation analysers.

Precautions for Clotting Time

• Mild coagulation abnormalities are not diagnosed.

• Blood should be drawn as gently as possible.

• To obtain a precise result, one must prevent premature activation of the clotting process.

• Prevent the sample from hemolyzing.

• It is crucial to learn the patient's history.

Drawbacks of Clotting Time

• This test is unreliable for identifying bleeding conditions.

• To identify slight bleeding problems, it is insensitive.

• Only the most serious bleeding conditions will be detected.

• The presence of aberrant coagulation cannot be ruled out by normal clotting time.

• The test's execution involves numerous variables.

• For regular preoperative screening for bleeding, such as in tonsillectomy, preoperative clotting time and bleeding time are of minimal benefit.

The Procedure of Clotting Time

Three methods can be estimated for clotting time:

Capillary Method

• Use the lancet to prick the finger.

• The capillary will instantly fill if you place it above the blood.

• Now, rupture the capillary at regular intervals.

• The endpoint and clotting time is when a clot begins to form.

Test Tube Method

• Conduct this experiment at 37 ° C.

• Start the timer after collecting 4 ml of blood with the tube method. Take note of the moment the clot development initially appears.

• To improve accuracy, this test can be performed in many tubes.

Lee and White Method

• Take two 10-centimetre externally borated siliconised tubes.

• These tubes are prewarmed in a water bath at 37 °C.

• Take a sample of blood, primarily from the antecubital vein.

• 1 mL of the blood is placed in each test tube after 2 to 2.5 mL of the blood is drawn.

• As soon as you notice the blood in the syringe, start two stopwatches.

• Keep the blood in the water bath and tilt each tube every 30 to 60 seconds to check for clotting.

• Tilt the tube beyond a 90-degree angle.

• As soon as you notice the clot in the tube, stop the stopwatch.

Disadvantages of Clotting Time

• This test has lost its value because it is insensitive.

• The method used to administer the test involves a lot of variables.

• This is unable to identify a mild coagulation factor deficit.

• Only in cases of extreme deficit is this test extended.

• Even while thrombocytopenia causes longer bleeding times, normal clotting times still exist.

What Is Deep Vein Thrombosis?

Deep vein thrombosis or DVT refers to a circulatory disorder characterised by the formation of a blood clot or thrombus in the deep vein, usually of the lower limbs.

• Causes: Prolonged immobility, surgery, certain medications.

• Symptoms: Swelling, pain, redness, and warmth in the affected leg.

• Complications: The clot breaks loose and travels in the bloodstream to the lungs where it causes a pulmonary embolism.

What is Thrombus or Thrombosis?

A blood clot in the circulatory system is known as a thrombus. It adheres to the area where it originated and stays there, obstructing blood flow. The medical word for the development of a thrombus is thrombosis.

A clot developing inside a blood vessel (an artery or vein) in your body, or occasionally inside your heart, is called thrombosis. This is a risk because blood vessel clots can restrict blood flow. They can also separate and move about throughout your body, and if a clot lodges itself in a vital organ like your brain or lungs, it may result in emergencies that could endanger your life.

People who are sedentary and those who have a hereditary propensity to blood clotting are more likely to develop thrombi. A thrombus can also develop after an artery, vein, or surrounding tissue is damaged.

Blood Coagulation Factors

Various factors could either impair or enhance blood coagulation, some of which will be discussed including specific proteins, genes, and lifestyle choices.

Coagulation Factors

• Plasma proteins that are essential for blood clotting.

• Major coagulation factors: I to XIII; each factor has a different function in the coagulation cascade, like Factor VIII in haemophilia A.

Genetic Factors

• Hemophilia: Genetic deficiency of clotting factors (Factor VIII or IX).

• Symptoms: Excessive bleeding, easy bruising.

• Treatment: Replacement therapy with clotting factor concentrates.

• Von Willebrand Disease: Deficiency or dysfunction of von Willebrand factor.

• Symptoms: Nosebleeds, heavy menstrual periods.

• Treatment: Medications to increase von Willebrand factor or clotting factor concentrates.

Environmental And Lifestyle Factors

• Diet and Nutrition: Vitamin K is needed for the synthesis of clotting factors.

• Medications and Blood Thinners: Aspirin, warfarin, and another anticoagulant will interfere with coagulation.

• Exercise and Physical Activity: Regular activity improves circulation, and prevents clot formation.

Causes of Thrombosis

The first step in preventing thrombosis is to determine the likelihood that it will occur. Some persons are more susceptible to thrombosis and the potential for thromboembolism. Some of these risk factors have an inflammatory component. The three elements required for the development of thrombosis—blood stasis, vascular wall damage, and altered blood coagulation—have been referred to as "Virchow's triad." While some risk factors enhance the likelihood of arterial thrombosis, others predispose to venous thrombosis. The risk of thromboembolism in newborn infants during the neonatal era is also present.

Prevention of Thrombosis

Heparin is frequently used after surgery if there are no bleeding complications. A risk-benefit analysis is typically necessary because all anticoagulants raise the risk of bleeding.

Thrombosis is a significant contributor to difficulties in hospital patients and occasionally fatalities. LMWH is also known to prevent thrombosis in patients with medical illnesses rather than surgical illnesses, and in the UK, the Chief Medical Officer has given recommendations to the effect that prophylactic measures should be employed in medical patients in advance of formal guidelines

Disorders of Blood Coagulation

The disorders lead to either an increase or a decrease in clotting, both conditions presenting significant health risks.

Hypercoagulability

• Excess clotting tendency due to genetic factors, drugs, or conditions such as cancer.

• Associated Conditions of Hypercoagulability: Deep vein thrombosis, pulmonary embolism

• Treatment Options and Management: Anticoagulants, lifestyle modifications

Hypercoagulability

• The low ability of blood to form clots is usually due to genetics or as an effect of drugs.

• Conditions Associated with Hypocoagulability: Hemophilia, von Willebrand disease.

• Treatment and Management: Replacement of clotting factors and supportive therapies.

Blood Coagulation Diagnostic Tests

Several tests are used to diagnose disorders of coagulation and monitor the treatment of these disorders.

Prothrombin Time (PT)

• Purpose and Procedure: This test will determine how long it takes for blood to clot. It measures the extrinsic pathway.

• Interpretation of Results: Prolonged PT indicates clotting disorders or vitamin K deficiency.

Activated Partial Thromboplastin Time

• Purpose and Procedure: This is a measure of the time blood takes to clot, and tests intrinsic pathways.

• Interpretation of Results: Long aPTT is indicative of haemophilia or heparin therapy.

D-Dimer Test

• Purpose and Procedure: Assay fragments produced in the process of clot breakdown; are used to diagnose thrombotic disorders.

• Interpretation of Results: Elevated values indicate active clot formation and lysis.

Platelet Count

• Purpose and Procedure: Determine the number of platelets present in blood.

• Interpretation of Results: Too few, thrombocytopenia, excessive bleeding; too many, thrombocytosis, tendency to form clots.

Conclusion

In order to prevent the body from losing too much blood, blood coagulation is the process of forming a clot or thrombus. Coagulation is the physiological process that causes a blood clot. Blood clotting typically takes between 10 and 13 seconds. A value outside of that range indicates that blood clots more slowly than usual.

Recommended video on Blood Coagulation